Quent Capital’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,116
Closed -$7.81K 1623
2025
Q4
$7.81K Hold
1,116
﹤0.01% 1201
2025
Q3
$8.63K Buy
+1,116
New +$8.71K ﹤0.01% 1045
2024
Q3
Sell
-203
Closed -$1.99K 1374
2024
Q2
$1.99K Buy
203
+24
+13% +$293 ﹤0.01% 1215
2024
Q1
$2.7K Sell
179
-54
-23% -$980 ﹤0.01% 1195
2023
Q4
$5.02K Sell
233
-275
-54% -$5.07K ﹤0.01% 1073
2023
Q3
$9.44K Sell
508
-148
-23% -$3.46K ﹤0.01% 945
2023
Q2
$16.6K Hold
656
﹤0.01% 823
2023
Q1
$17K Buy
656
+425
+184% +$11.4K ﹤0.01% 813
2022
Q4
$5.46K Buy
231
+49
+27% +$1.32K ﹤0.01% 994
2022
Q3
$5K Buy
182
+65
+56% +$2.28K ﹤0.01% 989
2022
Q2
$4K Buy
117
+113
+2,825% +$4.8K ﹤0.01% 994
2022
Q1
$0 Buy
+4
New +$288 ﹤0.01% 1325

Other funds holding TDOC

Quent Capital's TDOC Position: Q1 2026 in Review

Quent Capital sold out of Teladoc Health (TDOC) in Q1 2026, closing a stake of 1,116 shares — an estimated $7.81K sold.

Quent Capital first reported a position in TDOC in Q1 2022 and held it in 12 quarters. The position peaked at $17K in Q1 2023. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Quent Capital reported no remaining Teladoc Health position as of Q1 2026 after selling out during the quarter.
  • Quent Capital sold 1,116 Teladoc Health shares in Q1 2026, an estimated $7.81K.
  • Quent Capital first reported a position in Teladoc Health in Q1 2022 and held it in 12 quarters.
  • Quent Capital's Teladoc Health position peaked at $17K in Q1 2023.
  • 323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.